Our medicines
Our medicines
Our top priority is the health of Canadians. Their well-being is central to our work and drives our commitment to deliver a diverse portfolio of innovative treatments.
Links to information (product monographs) about our current medicines available to Canadians are listed below.
To contact Medical Information about our products or report an adverse event, visit our home page >.
ADDERALL XR® and ADDERALL® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc.
ADYNOVATE® is a registered trademark of Baxalta Incorporated.
ALUNBRIG® and the ALUNBRIG Logo® are registered trademarks of ARIAD Pharmaceuticals, Inc.
CINRYZE® and the CINRYZE Logo are registered trademarks of ViroPharma Biologics LLC, a Takeda company.
CUVITRU® is a registered trademark of Baxalta Incorporated.
DEXILANT® is a trademark of Takeda Pharmaceuticals U.S.A., Inc and used under licence by Takeda Canada Inc.
ELAPRASE® and the ELAPRASE Logo® are registered trademarks of Shire Human Genetic Therapies, Inc.
ENTYVIO® is a registered trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.
FEIBA® is a registered trademark of Baxalta Incorporated.
FIRAZYR® and the FIRAZYR Logo are registered trademarks of Shire Orphan Therapies GmbH.
FOSRENOL® and the FOSRENOL Logo are registered trademarks of Shire International Licensing BV, a Takeda company.
FRUZAQLATM and the FRUZAQLA Logo are trademarks of HUTCHMED Group Enterprises Limited, used under license.
GAMMAGARD® and GAMMAGARD LIQUID® are registered trademarks of Baxalta Incorporated.
GLASSIA® is a registered trademark used under license from Kamada Ltd.
HyQvia® is a registered trademark of Baxalta Incorporated.
IMMUNINE® is a registered trademark of Baxalta Incorporated.
INTUNIV XR® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.
KAZANO® is a registered trademark of Takeda Pharmaceutical Company Limited.
LIVTENCITY® and the LIVTENCITY Logo® are registered trademarks of Takeda Pharmaceuticals International AG.
MEZAVANT® and the MEZAVANT Logo® are registered trademarks of Nogra Pharma Limited, used under license.
NESINA® is a registered trademark of Takeda Pharmaceutical Company Limited.
NINLARO® is a registered trademark of Millennium Pharmaceuticals, Inc.
OBIZUR® is a registered trademark of Baxalta Incorporated.
ONDISSOLVE® is a registered trademark of Takeda GmbH.
PANTOLOC® and TECTA® are registered trademarks of Takeda GmbH. Used under licence.
REPLAGAL® and the REPLAGAL Logo® are registered trademarks of Shire Human Genetic Therapies, Inc.
REVESTIVE® is a registered trademark of Shire-NPS Pharmaceuticals, Inc., a Takeda company.
RIXUBIS® and BAXJECT® II are registered trademarks of Baxalta Incorporated.
TAKHZYRO® is a registered trademark of Dyax Corp.
ULORIC® is a registered trademark of Teijin Limited and used under licence by Takeda Canada Inc.
VONVENDI® is a registered trademark of Baxalta Incorporated.
VPRIV® and the VPRIV Logo® are registered trademarks of Shire Human Genetic Therapies, Inc.
Medications Return Program
Takeda is pleased to support the Medications Return Program of the Health Products Stewardship Association in Canada.
The Medications Return Program is a safe and easy way to responsibly dispose of expired or unneeded medications.
Medications covered under this program are:
- All prescription drugs
- Over-the-counter medications in oral dosage form (including pills/liquids).
- Natural health products in oral dosage form (including pills/liquids).
For more information, please speak to your pharmacist or use the online site locator to find a safe disposal drop-off location near you.
Don’t throw them away!